Advisor Group’s AnaptysBio ANAB Stock Holding History

Advisor Group’s Portfolio ANAB Stock Details ANAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$920K	Sell	56,602 -2	-0%	-$47	0.01%	1250
2019 Q3	$1.98M	Buy	56,604 +2	+0%	+$95	0.01%	767
2019 Q2	$3.19M	Sell	56,602 -56,098	-50%	-$4.04M	0.02%	569
2019 Q1	$8.23M	Sell	112,700 -10,000	-8%	-$690K	0.07%	249
2018 Q4	$7.83M	Buy	+122,700	New	+$9.12M	0.08%	220
2018 Q2	–	Sell	-3,730	Closed	-$388K	–	4914
2018 Q1	$388K	Buy	+3,730	New	+$420K	0.01%	1495

Other funds holding ANAB

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Advisor Group's ANAB Position: Q4 2019 in Review

Advisor Group reduced its AnaptysBio (ANAB) stake by 0% in Q4 2019, selling an estimated $47 and leaving 56,602 shares worth $920K. The position accounts for 0.01% of the portfolio, ranked #1250.

Advisor Group first reported a position in ANAB in Q1 2018 and has held it in 6 quarters since. The position peaked at $8.23M in Q1 2019. 121 funds tracked by Wall St. Rank hold ANAB as of Q4 2019.

Advisor Group held 56,602 shares of AnaptysBio worth $920K as of Q4 2019.
Advisor Group sold 2 AnaptysBio shares in Q4 2019, an estimated $47.
AnaptysBio made up 0.01% of Advisor Group's portfolio in Q4 2019, its #1250 holding.
Advisor Group first reported a position in AnaptysBio in Q1 2018 and has held it in 6 quarters since.
Advisor Group's AnaptysBio position peaked at $8.23M in Q1 2019.
121 funds tracked by Wall St. Rank held AnaptysBio as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.